Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Biochim Biophys Acta. 2014 Nov 11;1852(1):34–46. doi: 10.1016/j.bbadis.2014.11.006

Figure 5. C66 prevented diabetes-induced renal histone acetylation.

Figure 5

Expression of renal H3K9/14 was measured by (A, B) western blotting assay and (C) immunofluorescence staining at (A, C) 3 months of treatment and (B, C) 6 months after treatment (equating to 3 months after treatment termination). In panel C, H3K9/14 is shown as present (green fluorescence) in the nuclei (blue fluorescence; DAPI staining) of both glomerular cells and renal tubular cells; original magnification: ×200. Data are presented as mean ± SD after normalizing to control (n≥4). * P < 0.05 vs. control group; # P < 0.05 vs. DM group. Bar: 50 µm.